Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)

JOURNAL ARTICLE published November 2021 in Gynecologic Oncology

Authors: Stephanie Gaillard | Ana Oaknin | Isabelle Ray-Coquard | Ignace Vergote | Giovanni Scambia | Nicoletta Colombo | Cristian Fernandez | Vicente Alfaro | Carmen Kahatt | Antonio Nieto | Ali Zeaiter | Miguel Aracil | Laura Vidal | Beatriz Pardo-Burdalo | Zsuzsanna Papai | Rebecca Kristeleit | David M. O'Malley | Ivor Benjamin | Patricia Pautier | Domenica Lorusso